Cost-of-Illness StudiesA Review of Current Methods

被引:0
|
作者
Ebere Akobundu
Jing Ju
Lisa Blatt
C. Daniel Mullins
机构
[1] University of Maryland School of Pharmacy,Pharmaceutical Health Services Research Department, School of Pharmacy
来源
PharmacoEconomics | 2006年 / 24卷
关键词
Irritable Bowel Syndrome; Incremental Cost; Disease Category; Healthcare Expenditure; Medical Method;
D O I
暂无
中图分类号
学科分类号
摘要
The number of cost-of-illness (COI) studies has expanded considerably over time. One outcome of this growth is that the reported COI estimates are inconsistent across studies, thereby raising concerns over the validity of the estimates and methods. Several factors have been identified in the literature as reasons for the observed variation in COI estimates. To date, the variation in the methods used to calculate costs has not been examined in great detail even though the variations in methods are a major driver of variation in COI estimates. The objective of this review was to document the variation in the methodologies employed in COI studies and to highlight the benefits and limitations of these methods.
引用
收藏
页码:869 / 890
页数:21
相关论文
共 50 条
  • [1] Cost-of-illness studies - A review of current methods
    Akobundu, Ebere
    Ju, Jing
    Blatt, Lisa
    Mullins, C. Daniel
    [J]. PHARMACOECONOMICS, 2006, 24 (09) : 869 - 890
  • [2] Cost-of-Illness StudiesA Guide to Critical Evaluation
    Allison Larg
    John R. Moss
    [J]. PharmacoEconomics, 2011, 29 : 653 - 671
  • [3] Cost-of-Illness Studies: An Updated Review of Current Methods
    Eberechukwu Onukwugha
    Jacquelyn McRae
    Alex Kravetz
    Stefan Varga
    Rahul Khairnar
    C. Daniel Mullins
    [J]. PharmacoEconomics, 2016, 34 : 43 - 58
  • [4] Cost-of-Illness Studies: An Updated Review of Current Methods
    Onukwugha, Eberechukwu
    McRae, Jacquelyn
    Kravetz, Alex
    Varga, Stefan
    Khairnar, Rahul
    Mullins, C. Daniel
    [J]. PHARMACOECONOMICS, 2016, 34 (01) : 43 - 58
  • [5] A review of cost-of-illness studies on obesity
    Kortt, MA
    Langley, PC
    Cox, ER
    [J]. CLINICAL THERAPEUTICS, 1998, 20 (04) : 772 - 779
  • [6] Cost-of-illness of epilepsy: a current state of the problem
    Mizinova, M. A.
    Milchakova, L. E.
    Magomedova, A. Kh
    Shpak, A. A.
    Guekht, A. B.
    [J]. ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2013, 113 (01) : 82 - 84
  • [7] Cost-of-illness studies: concepts, scopes, and methods
    Jo, Changik
    [J]. CLINICAL AND MOLECULAR HEPATOLOGY, 2014, 20 (04) : 327 - 337
  • [8] A SYSTEMETIC REVIEW OF COST-OF-ILLNESS STUDIES ON MULTIMORBIDITY
    Wang, L.
    Si, L.
    Palmer, A. J.
    Cocker, F.
    Sanderson, K.
    [J]. VALUE IN HEALTH, 2017, 20 (05) : A32 - A32
  • [9] Cost-of-Illness of Skin Cancer: A Systematic Review
    Meertens, Annick
    Van Coile, Laura
    Van Iseghem, Tijs
    Brochez, Lieve
    Verhaeghe, Nick
    Hoorens, Isabelle
    [J]. PHARMACOECONOMICS, 2024, 42 (07) : 751 - 765
  • [10] A Systematic Review of Cost-of-Illness Studies of Multimorbidity
    Wang, Lili
    Si, Lei
    Cocker, Fiona
    Palmer, Andrew J.
    Sanderson, Kristy
    [J]. APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2018, 16 (01) : 15 - 29